Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever

This article was originally published in The Tan Sheet

Executive Summary

Ad spend allocations shifted to emphasize 400 core brands, firm says. Brands that do not rank in top two within their category will be marketed without promotions, divested or cease to be manufactured within four years, company says. Strategy is part of portfolio restructuring announced in 1999. Firm already has divested more than half of proposed 1,200 brands to be disposed. Additional 8,000 job cuts, 30 factory closings announced during recent analysts call. Primarily related to Best Foods acquisition, new round of cuts follows original 25,000 announced last year

You may also be interested in...



Unilever Exiting OTC Diagnostics Business With Unipath Sale

Unilever plans to divest its nearly $90 mil. Unipath women's health diagnostics business, which includes the Clearblue line of home pregnancy test kits, to focus on selected consumer brands, the firm said June 19.

Unilever Exiting OTC Diagnostics Business With Unipath Sale

Unilever plans to divest its nearly $90 mil. Unipath women's health diagnostics business, which includes the Clearblue line of home pregnancy test kits, to focus on selected consumer brands, the firm said June 19.

Unilever Exiting OTC Diagnostics Business With Unipath Sale

Unilever plans to divest its nearly $90 mil. Unipath women's health diagnostics business, which includes the Clearblue line of home pregnancy test kits, to focus on selected consumer brands, the firm said June 19.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel